RS
ALNY icon

Rakuten Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History

Rakuten Securities’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.53K Buy
25
+7
+39% +$2.11K ﹤0.01% 502
2026
Q1 		$5.96K Sell
18
-171
-90% -$58.2K ﹤0.01% 482
2025
Q4 		$75.2K Buy
189
+185
+4,625% +$81.9K 0.02% 207
2025
Q3 		$1.82K Buy
+4
New +$1.63K ﹤0.01% 637
2024
Q4 		– Sell
-11
Closed -$3.02K – 764
2024
Q3 		$3.02K Sell
11
-54
-83% -$14.1K ﹤0.01% 474
2024
Q2 		$15.8K Sell
65
-135
-68% -$21.3K 0.01% 286
2024
Q1 		$29.9K Buy
+200
New +$33.4K 0.01% 228

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rakuten Securities's ALNY Position: Q2 2026 in Review

Rakuten Securities increased its Alnylam Pharmaceuticals (ALNY) stake by 39% in Q2 2026, buying an estimated $2.11K and bringing the position to 25 shares worth $7.53K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

Rakuten Securities first reported a position in ALNY in Q1 2024 and has held it in 7 quarters since. The position peaked at $75.2K in Q4 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Rakuten Securities held 25 shares of Alnylam Pharmaceuticals worth $7.53K as of Q2 2026.
  • Rakuten Securities bought 7 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.11K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #502 holding.
  • Rakuten Securities first reported a position in Alnylam Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Rakuten Securities's Alnylam Pharmaceuticals position peaked at $75.2K in Q4 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.